0. HROMATKO, I., TADINAC, M. (2006), Testosterone levels influence spatial ability: Further evidence for curvilinear relationship. Review of Psychology, 13, 1, 27-34, .
0. HROMATKO, I., TADINAC, M. (2009), Frontalne EEG asimetrije i raspoloženje u funkciji mentrualnog ciklusa, u: Ljubotina, D., Kamenov, Ž., Mikac, U., Urch, D. (ur.) Sažeci priopćenja - 19. Dani Ramira i Zorana Bujasa, 115, Zagreb.
0. HUBER, B. (2007), Fatal hepatoxicity possibly associated with Valproate after 21 years of therapy. 6th European Congress of Mental Health in Intellectual Disability, Abstracts, p. 112, Zagreb.
0. HUCKLEBRIDGE, F., CLOW, A., LEMBERT, S., EVANS, P. (1998), Evidence for the inhibitory influence of the HPA axis on mucosal immunity. U: Lacković-Grgin, K. (ur.) Sažetci radova - 11. Dani psihologije, Odsjek za psihologiju, Filozofski fakultet u Zadru, str. 27, .
0. KÁROSSY, K., KEREKES, Z., HORVÁTH, D., GŐCZE, P., KÁLLAI, J. (2007), Association of high and low density serum cholesterol, cognitive performance and emotional well-being in menopausal women. Review of Psyhology 14, 13-23, . ( serum cholesterol, LDL, HDL, cognitive performance, emotional well being, menopause )
0. LAMBERT, S., HUCKLEBRIDGE, F., EVANS, P., CLOW, A. (1998), Positive and negative mood states: do they differentially affect the mucosal immune system? U: Lacković-Grgin, K. (ur.) Sažetci radova - 11. Dani psihologije, Odsjek za psihologiju, Filozofski fakultet u Zadru, str. 34, .
0. MARIČIĆ, A., PALMOVIĆ, M. (2008), Utjecaj lažnih informacija na širinu zjenice. U: Vulić-Prtorić, A., Ćubela Adorić, V., Proroković, A., Sorić, I., Valerjev, P. (ur.) Sažetci radova - 16. Dani psihologije, str. 81, Zadar.
0. MIMICA, N., UZUN, S., FOLENGOVIĆ-ŠMALC, V., MARKAN-ŠOŠIĆ, V., LJUBIN, T. (2001), Sertraline: a novel antidepressant with a broad treatment spectrum. Period Biol, 103, 301-308, .
0. MIROŠEVIĆ, M., KARDUM, G. (2009), The influence of alcochol-inuced cerebellar atrophy on respiratory rhythms at rest. Alcoholism, 45, 2, 81-93, .
0. NOVELL, R., ESTEBA, S., RIBAS, N., CHALER, R. (2007), Dementia and Down syndrome: NMDA treatment. 6th European Congress of Mental Health in Intellectual Disability, Abstracts, p. 120, Zagreb.
0. UZUN, S., FOLNEGOVIĆ-ŠMALC, V., MIMICA, N., LJUBIN, T., MAKARIĆ, G., IVEZIĆ, S., JELAČIĆ, P., VILIBIĆ, M., MARKAN-ŠOŠIĆ, V. (2002), Ziprasidone clinical trials conducted in Croatia. Schizophrenia Research, 53/3 (Special Issue), 182, .
0. UZUN, S., MIMICA, N., FOLNEGOVIĆ-ŠMALC, V., MARKAN-ŠOŠIĆ, V., LJUBIN, T. (2003), Ziprasidone: an overview of clinical trials of a novel antipsychotic conducted in Croatia. Period Biol, 105, 71-80, .